Khodosovskiĭ M N, Zinchuk V V
Department of Biochemistry, Grodno State Medical University, ul. M. Gor'kogo 80, Grodno, 230015 Belarus.
Eksp Klin Farmakol. 2003 May-Jun;66(3):39-43.
The L-arginine--NO system functioning in rabbits with hepatic ischemia and reperfusion was modified by infusing the NO synthase (NOS) inhibitor NG-nitro-L-arginine (15 mg/kg) or the NOS substrate L-arginine (300 mg/kg). The effect was evaluated by determining the lipid peroxidation (LPO) products (conjugated dienes, Schiff bases) and antioxidant system factors (alpha-tocopherol, retinol, catalase activity factor). The degree of reperfusive damage was evaluated by the alanine amino transferase (AlAT) and aspartate amino transferase (AsAT) activity in the blood of experimental animals. The development of ischemia and reperfusion leads to a significant growth in the LPO rate, depletion of the antioxidant system factors in the blood and liver tissue, and increase in the AlAT and AsAT activity. The L-arginine infusion prior to the reperfusion period decreased violation of the prooxidant-antioxidant state and favored normalization of the AlAT and AsAT activity in the blood. No such effects were observed as a result of the NOS inhibition prior to the onset of ischemia.
通过输注一氧化氮合酶(NOS)抑制剂NG-硝基-L-精氨酸(15毫克/千克)或NOS底物L-精氨酸(300毫克/千克),对肝缺血再灌注家兔体内的L-精氨酸-一氧化氮系统功能进行了调节。通过测定脂质过氧化(LPO)产物(共轭二烯、席夫碱)和抗氧化系统因子(α-生育酚、视黄醇、过氧化氢酶活性因子)来评估其效果。通过实验动物血液中的丙氨酸氨基转移酶(AlAT)和天冬氨酸氨基转移酶(AsAT)活性来评估再灌注损伤的程度。缺血和再灌注的发展导致LPO速率显著增加、血液和肝组织中的抗氧化系统因子耗竭以及AlAT和AsAT活性增加。在再灌注期之前输注L-精氨酸可减少促氧化剂-抗氧化剂状态的破坏,并有利于血液中AlAT和AsAT活性的正常化。在缺血发作之前抑制NOS未观察到此类效果。